Skip to content
Life sciences consumables, equipment and services, delivered across Saudi Arabia.
Human Podocalyxin PharmaGenie ELISA Kit (SBRS1004)
  • Human Podocalyxin PharmaGenie ELISA Kit (SBRS1004)
Assay Genie

Human Podocalyxin PharmaGenie ELISA Kit (SBRS1004)

Price on request

SKUPriceQuantity
SBRS1004

Price on request

Description

This description has not been verified against the manufacturer's datasheet. Check the datasheet before you order, or ask us to confirm a specification. Ask us to confirm

Podocalyxin is a heavily glycosylated transmembrane sialomucin first characterized on glomerular podocytes, where it contributes to maintaining the architecture of the renal filtration barrier. The Human Podocalyxin PharmaGenie ELISA Kit from Assay Genie is a quantitative immunoassay that supports researchers investigating PODXL expression in human-derived samples. Outside the kidney, PODXL has attracted interest as a cancer biomarker: increased expression on tumor cells has been associated with aggressive disease and poor prognosis in breast, pancreatic, and prostate cancers, while circulating podocalyxin fragments are being investigated as blood-based sentinels of tumor burden, vascular injury, and glomerular damage.

This colorimetric assay is supplied as a complete reagent set configured for 96 individual reactions and is validated for measurement of podocalyxin in serum samples, plasma samples, and cell culture supernatant. Each kit contains the pre-coated microplate, detection antibodies, standards for curve generation, and the buffers and substrates required to run the assay under standard ELISA conditions. The kit is intended for laboratory research use in fields including nephrology, oncology biomarker discovery, stem cell characterization, and vascular biology, where it can be applied to disease models, therapeutic screening studies, and patient sample profiling.

Components should be stored as indicated in the product insert to maintain activity through the kit's shelf life. For research use only.